Exclusive

Publication

Byline

Protesters in Mussoorie raise questions on Uttarakhand's Silver Jubilee celebrations

Dehradun, Nov. 7 -- Garhwal Post Bureau Mussoorie, 5 Nov: At a programme organised to mark the Silver Jubilee of the formation of Uttarakhand, protestors and speakers remembered the martyrs' sacrific... Read More


'Maharani' season 4 ending explained: Who betrayed Rani Bharti and helped PM Joshi win?

India, Nov. 7 -- Maharani season 4 ending, explained: If Indian political dramas have taught us anything, it's that road to power is essentially a family WhatsApp group gone wrong. The fourth season o... Read More


COP30: Indonesia pledges stronger climate action at leader summit

Belem, Brazil, Nov. 7 -- Indonesia reaffirmed its commitment to strengthening national climate action during the Belem Leader Summit in Brazil, according to President Prabowo Subianto's Special Envoy ... Read More


Two years on from EU deal, violence against migrants in Tunisia remains rife

France, Nov. 7 -- Tunisia's migration policy is under scrutiny two years on from a deal with the European Union intended to discourage illegal migration from the North African country, and from a "rep... Read More


Inside Lily Allen's messy dating history: 5 relationships, 2 divorces and 1 break-up album

India, Nov. 7 -- If you have been waking up to endless headlines about Lily Allen, her relationships and other controversial details from her dating history these past few days, you're definitely not ... Read More


Studds Accessories slides on debut

Mumbai, Nov. 7 -- The stock was listed at Rs 570, reflecting a discount of 2.56% to the issue price. So far, the stock has hit a high of 585 and a low of 555.80. On the BSE, over 4.13 lakh shares of ... Read More


Clinical Trial: Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225439) titled 'Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relap... Read More


Clinical Trial: Shifting Options Study

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225595) titled 'Shifting Options Study' on Nov. 19, 2024. Brief Summary: The goal of Shifting Options is to... Read More


Clinical Trial: The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225608) titled 'The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Ener... Read More


Clinical Trial: Personalizing Financial Incentives

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225426) titled 'Personalizing Financial Incentives' on Nov. 04. Brief Summary: The purpose of this study is... Read More